First European psychedelic drug trial clinic opens in the U.K.
Clerkenwell Health will begin trials in its London in August, initially focusing on psilocybin treatments and poised to make the UK a leader psychedelic research.
Clerkenwell Health will begin trials in its London in August, initially focusing on psilocybin treatments and poised to make the UK a leader psychedelic research.
The new study led by researchers from Imperial College London found that people also reported a reduction in their depression symptoms alongside these brain changes.